Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE.

J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9. Epub 2007 May 9. Review.

PMID:
17519979
2.

Consensus nomenclature: its time has come.

Innis RB, Carson R.

Eur J Nucl Med Mol Imaging. 2007 Aug;34(8):1239. No abstract available.

PMID:
17508212
3.

Stereoselective neuroimaging in vivo.

Smith DF, Jakobsen S.

Eur Neuropsychopharmacol. 2007 Jul;17(8):507-22. Epub 2007 Mar 23. Review.

PMID:
17368004
4.

Availability of molecular imaging and "personalized medicine.".

Baranowska-Kortylewicz J, Henriksen JB.

J Nucl Med. 2009 Jan;50(1):16N. No abstract available.

5.

[Strategy for development of imaging biomarkers].

Ishiwata K.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2009 Apr;29(2):67-71. Review. Japanese.

PMID:
19562944
6.

Molecular imaging targeting peptide receptors.

Schottelius M, Wester HJ.

Methods. 2009 Jun;48(2):161-77. doi: 10.1016/j.ymeth.2009.03.012. Epub 2009 Mar 24. Review.

PMID:
19324088
7.

Rising costs of medical imaging spur debate.

Rowan K.

J Natl Cancer Inst. 2008 Dec 3;100(23):1665-7. doi: 10.1093/jnci/djn430. Epub 2008 Nov 25. No abstract available.

PMID:
19033570
8.

Multimodality cardiovascular molecular imaging, part I.

Sinusas AJ, Bengel F, Nahrendorf M, Epstein FH, Wu JC, Villanueva FS, Fayad ZA, Gropler RJ.

Circ Cardiovasc Imaging. 2008 Nov;1(3):244-56. doi: 10.1161/CIRCIMAGING.108.824359. Review.

9.

Development of Alzheimer's disease imaging agents for clinical studies.

Ryu EK, Chen X.

Front Biosci. 2008 Jan 1;13:777-89. Review.

PMID:
17981587
10.

Chemistry of molecular imaging.

Meade TJ, Aime S.

Acc Chem Res. 2009 Jul 21;42(7):821. doi: 10.1021/ar900166c. No abstract available.

PMID:
19527053
11.

Molecular imaging I. Foreword.

Bräutigam M, Dinkelborg L.

Handb Exp Pharmacol. 2008;(185 Pt 1):v-vi. No abstract available.

PMID:
18763374
12.

Translational imaging: imaging of apoptosis.

Strauss HW, Blankenberg F, Vanderheyden JL, Tait J.

Handb Exp Pharmacol. 2008;(185 Pt 2):259-75. doi: 10.1007/978-3-540-77496-9_11. Review.

PMID:
18626606
13.

Molecular imaging I. Preface.

Semmler W, Schwaiger M.

Handb Exp Pharmacol. 2008;(185 Pt 1):vii-ix. No abstract available.

PMID:
18763375
14.

Opportunities, challenges, and caveats of successful molecular imaging of cardiovascular diseases.

Levkau B.

Basic Res Cardiol. 2008 Mar;103(2):79-81. doi: 10.1007/s00395-008-0705-4. No abstract available.

PMID:
18324362
15.

Molecular imaging of atheroslerotic plaque with nuclear medicine techniques.

Schillaci O, Danieli R, Padovano F, Testa A, Simonetti G.

Int J Mol Med. 2008 Jul;22(1):3-7. Review.

PMID:
18575769
17.

Molecular Imaging II. Foreword.

Brautigam M, Dinkelborg L.

Handb Exp Pharmacol. 2008;(185 Pt 2):v-vi. No abstract available.

PMID:
18788124
19.

Molecular Imaging II. Preface.

Semmler W, Schwaiger M.

Handb Exp Pharmacol. 2008;(185 Pt 2):vii-ix. No abstract available.

PMID:
18788125
20.

Current topics in the development of radioligands for positron-emission tomography imaging.

Horti AG, Dannals RF.

Curr Top Med Chem. 2010;10(16):1584. No abstract available.

PMID:
20868363

Supplemental Content

Support Center